A Phase II Study of Intraperitoneal Cisplatin and Thiotepa in Residual Ovarian Carcinoma: A Gynecologic Oncology Group Study

Oncology Group ◽

A phase II study of PAL A (NSC 224131) in patients with advanced ovarian carcinoma A Gynecologic Oncology Group study

American Journal of Clinical Oncology ◽

10.1097/00000421-198406000-00011 ◽

1984 ◽

Vol 7 (3) ◽

pp. 257-260 ◽

Cited By ~ 3

Author(s):

Hyman B. Muss ◽

Milan Slavik ◽

Brian Bundy ◽

Frederick B. Stehman ◽

William T. Creasman

Keyword(s):

Ovarian Carcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Advanced Ovarian Carcinoma

Phase II Study of Ifosfamide and Mesna in Nonsquamous Carcinoma of the Cervix: A Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1006/gyno.1993.1084 ◽

1993 ◽

Vol 49 (1) ◽

pp. 48-50 ◽

Cited By ~ 25

Author(s):

Gregory P. Sutton ◽

John A. Blessing ◽

Philip J. DiSaia ◽

William P. McGuire

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Oncology Group ◽

Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2006.03.043 ◽

2006 ◽

Vol 103 (2) ◽

pp. 523-526 ◽

Cited By ~ 30

Author(s):

Paula M. Fracasso ◽

John A. Blessing ◽

Kelly L. Molpus ◽

Lisa M. Adler ◽

Joel I. Sorosky ◽

...

Keyword(s):

Endometrial Carcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Second Line ◽

Oncology Group ◽

Oncology Group Study ◽

Second Line Chemotherapy ◽

Line Chemotherapy

A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254)

Gynecologic Oncology ◽

10.1016/j.ygyno.2018.05.029 ◽

2018 ◽

Vol 150 (2) ◽

pp. 247-252 ◽

Cited By ~ 18

Author(s):

John K. Chan ◽

William Brady ◽

Bradley J. Monk ◽

Jubilee Brown ◽

Mark S. Shahin ◽

...

Keyword(s):

Ovarian Carcinoma ◽

Phase Ii ◽

Clear Cell ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Clear Cell Ovarian Carcinoma

Phase II study of esorubicin (4?-deozydoxorubicin) in advanced epithelial carcinoma of the ovary: A Gynecologic Oncology Group study

Investigational New Drugs ◽

10.1007/bf00173763 ◽

1989 ◽

Vol 7 (4) ◽

Cited By ~ 1

Author(s):

WilliamP. McGuire ◽

JohnA. Blessing ◽

MichaelL. Berman

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Carcinoma Of The Ovary

2A phase II study to determine the response to second curettage as initial management for persistent “low-risk” non-metastatic gestational trophoblastic neoplasia: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2014.07.079 ◽

2014 ◽

Vol 134 (2) ◽

pp. 438-439 ◽

Cited By ~ 1

Author(s):

R.J. Osborne ◽

V.L. Filiaci ◽

R.S. Mannel ◽

S.A. Davidson ◽

J.S. Hoffman ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Low Risk ◽

Gestational Trophoblastic Neoplasia ◽

Oncology Group ◽

Initial Management ◽

A Phase II Study of Topotecan in Patients with Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1006/gyno.2000.6024 ◽

2001 ◽

Vol 81 (2) ◽

pp. 213-215 ◽

Cited By ~ 78

Author(s):

Laila I. Muderspach ◽

John A. Blessing ◽

Charles Levenback ◽

James L. Moore

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Oncology Group ◽

Phase II study of maytansine in the treatment of advanced or recurrent adenocarcinoma of the ovary A Gynecologic Oncology Group Study

American Journal of Clinical Oncology ◽

10.1097/00000421-198306000-00003 ◽

1983 ◽

Vol 6 (3) ◽

pp. 273-276 ◽

Cited By ~ 16

Author(s):

J. Tate Thigpen ◽

Clarence E. Ehrlich ◽

William T. Creasman ◽

Stephen Curry ◽

John A. Blessing

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Adenocarcinoma Of The Ovary

Intraperitoneal Interferon-α in Residual Ovarian Carcinoma: A Phase II Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1006/gyno.1999.5532 ◽

1999 ◽

Vol 75 (1) ◽

pp. 10-14 ◽

Cited By ~ 48

Author(s):

Jonathan S. Berek ◽

Maurie Markman ◽

Bette Stonebraker ◽

Samuel S. Lentz ◽

Mark D. Adelson ◽

...

Keyword(s):

Ovarian Carcinoma ◽

Phase Ii ◽

Gynecologic Oncology ◽

Interferon Α ◽

Oncology Group ◽

A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D

Journal of Gynecologic Oncology ◽

10.3802/jgo.2019.30.e112 ◽

2019 ◽

Vol 30 (6) ◽

Cited By ~ 2

Author(s):

Jung-Yun Lee ◽

Jae Weon Kim ◽

Myong Cheol Lim ◽

Sunghoon Kim ◽

Hee Seung Kim ◽

...

Keyword(s):

Ovarian Cancer ◽

Neoadjuvant Chemotherapy ◽

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Advanced Stage ◽

Oncology Group ◽